Rhenman & Partners Asset Management Ab Bio Techne Corp Transaction History
Rhenman & Partners Asset Management Ab
- $959 Million
- Q4 2024
A detailed history of Rhenman & Partners Asset Management Ab transactions in Bio Techne Corp stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 3,000 shares of TECH stock, worth $194,760. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,000
Previous 20,000
85.0%
Holding current value
$194,760
Previous $1.6 Million
86.48%
% of portfolio
0.02%
Previous 0.13%
Shares
7 transactions
Others Institutions Holding TECH
# of Institutions
615Shares Held
156MCall Options Held
161KPut Options Held
12.7K-
Vanguard Group Inc Valley Forge, PA18.6MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15MShares$973 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.7MShares$692 Million0.09% of portfolio
-
State Street Corp Boston, MA6.47MShares$420 Million0.02% of portfolio
-
Morgan Stanley New York, NY4.76MShares$309 Million0.02% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.55B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...